In the BioHarmony Drug Report Database
Exemestane
Aromasin (exemestane) is a small molecule pharmaceutical. Exemestane was first approved as Aromasin on 1999-10-21. It is used to treat breast neoplasms in the USA. The pharmaceutical is active against aromatase.
Trade Name
|
Aromasin |
|---|---|
Common Name
|
exemestane |
ChEMBL ID
|
CHEMBL1200374 |
Indication
|
breast neoplasms |
Drug Class
|
Antineoplastics (aromatase inhibitors) |
Image (chem structure or protein)